Skip to main content
Top
Published in: Acta Diabetologica 1/2013

01-02-2013 | Original Article

Fulminant type 1 diabetes: a collaborative clinical cases investigation in China

Authors: Shuoming Luo, Zhenyi Zhang, Xia Li, Lin Yang, Jian Lin, Xiang Yan, Zhen Wang, Chao Zheng, Gan Huang, Zhiguang Zhou

Published in: Acta Diabetologica | Issue 1/2013

Login to get access

Abstract

To clarify the detailed distribution, clinical and immunological features of patients with fulminant type 1 diabetes (F1D), we consecutively investigated 53 cases from nationwide 24 hospitals in China. After the clinical and immunological features were evaluated, we compared pregnancy-associated F1D (PF) with those of child-bearing age with F1D that was not associated with pregnancy in clinical characteristics. As a result, patients with F1D were reported from all over China, and there was no significant regional and seasonal preference of this disease. Around 34.0% (18/53) patients displayed low titers of autoantibodies against one or more autoantigens, including 12 cases positive for GADA, 2 for IA-2A, 4 for ZnT8A and 3 for both GADA and ZnT8A. The frequency of PF in female F1D was 34.6% (9/26). Among 9 PF patients, 8 (88.9%) developed F1D during pregnancy which resulted in stillbirth, while one had the onset of F1D after eutocia with her fetus survived. This study suggests that islet-associated autoimmunity may be involved in and contribute to the development of F1D. Pregnant women may be PF high-risk population, and the prognosis for the fetus is extremely poor in PF patients.
Literature
1.
go back to reference Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301–307PubMedCrossRef Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301–307PubMedCrossRef
2.
go back to reference Hanafusa T, Imagawa A (2007) Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3: 36–45; quiz 32p following 69 Hanafusa T, Imagawa A (2007) Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3: 36–45; quiz 32p following 69
3.
go back to reference Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H (2003) Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26:2345–2352PubMedCrossRef Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H (2003) Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26:2345–2352PubMedCrossRef
4.
go back to reference Tanaka S, Endo T, Aida K, Shimura H, Yokomori N, Kaneshige M, Furuya F, Amemiya S, Mochizuki M, Nakanishi K, Kobayashi T (2004) Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Diabetes Care 27:1936–1941PubMedCrossRef Tanaka S, Endo T, Aida K, Shimura H, Yokomori N, Kaneshige M, Furuya F, Amemiya S, Mochizuki M, Nakanishi K, Kobayashi T (2004) Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Diabetes Care 27:1936–1941PubMedCrossRef
6.
go back to reference Kim NH, Kim HY, Seo JA, Choi KM, Baik SH, Choi DS, Kim SG (2009) A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan. Diabetes Res Clin Pract 86:e43–e45PubMedCrossRef Kim NH, Kim HY, Seo JA, Choi KM, Baik SH, Choi DS, Kim SG (2009) A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan. Diabetes Res Clin Pract 86:e43–e45PubMedCrossRef
7.
go back to reference Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B (2008) Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 34:529–532PubMedCrossRef Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B (2008) Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 34:529–532PubMedCrossRef
8.
go back to reference Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS (2006) Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 54:S14–S17PubMedCrossRef Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS (2006) Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 54:S14–S17PubMedCrossRef
9.
go back to reference Pozzilli P, Visalli N, Leslie D, Grp I (2000) No evidence of rapid onset (Japanese) Type I diabetes in Caucasian patients. Diabetologia 43:1332–1332PubMedCrossRef Pozzilli P, Visalli N, Leslie D, Grp I (2000) No evidence of rapid onset (Japanese) Type I diabetes in Caucasian patients. Diabetologia 43:1332–1332PubMedCrossRef
10.
go back to reference Zhang C, Zhou Z, Zhang D, Yang X, Zhou M, Lin J, Huang G, Wang J (2005) Clinical and immunological characteristics in rapid-onset type 1 dibetes with hyperamylasemia. Natl Med J China 85:967–971 Zhang C, Zhou Z, Zhang D, Yang X, Zhou M, Lin J, Huang G, Wang J (2005) Clinical and immunological characteristics in rapid-onset type 1 dibetes with hyperamylasemia. Natl Med J China 85:967–971
11.
go back to reference Zhou J, Bao Y, Li M, Liu F, Chen H, Han J, Lu W, Ma X, Hu C, Xiang K, Jia W (2009) Fulminant type l diabetes: the clinical features and treatment strategy. Chin J Diabetes Mellitus 1:34–38 Zhou J, Bao Y, Li M, Liu F, Chen H, Han J, Lu W, Ma X, Hu C, Xiang K, Jia W (2009) Fulminant type l diabetes: the clinical features and treatment strategy. Chin J Diabetes Mellitus 1:34–38
12.
go back to reference Zheng C, Lin J, Huang G, Yang L, Zhang YY, Zhou WD, Zhou HF, Yang YL, Che ZH, Zhou ZG (2009) Immunological features of fulminant type 1 diabetes. Zhonghua Yi Xue Za Zhi 89:2544–2547PubMed Zheng C, Lin J, Huang G, Yang L, Zhang YY, Zhou WD, Zhou HF, Yang YL, Che ZH, Zhou ZG (2009) Immunological features of fulminant type 1 diabetes. Zhonghua Yi Xue Za Zhi 89:2544–2547PubMed
13.
go back to reference Feng YF, Yao MF, Li Q, Sun Y, Li CJ, Shen JG (2010) Fulminant type 1 diabetes in China: a case report and review of the literature. J Zhejiang Univ Sci B 11:848–850PubMedCrossRef Feng YF, Yao MF, Li Q, Sun Y, Li CJ, Shen JG (2010) Fulminant type 1 diabetes in China: a case report and review of the literature. J Zhejiang Univ Sci B 11:848–850PubMedCrossRef
14.
go back to reference Zheng C, Zhou Z, Yang L, Lin J, Huang G, Li X, Zhou W, Wang X, Liu Z (2011) Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes Metab Res Rev 27:70–78PubMedCrossRef Zheng C, Zhou Z, Yang L, Lin J, Huang G, Li X, Zhou W, Wang X, Liu Z (2011) Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes Metab Res Rev 27:70–78PubMedCrossRef
15.
go back to reference Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T (2006) Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab 91:471–476PubMedCrossRef Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T (2006) Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab 91:471–476PubMedCrossRef
16.
go back to reference Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467PubMedCrossRef Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467PubMedCrossRef
17.
go back to reference Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040–17045PubMedCrossRef Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040–17045PubMedCrossRef
18.
go back to reference Cho YM, Kim JT, Ko KS, Koo BK, Yang SW, Park MH, Lee HK, Park KS (2007) Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 50:2276–2279PubMedCrossRef Cho YM, Kim JT, Ko KS, Koo BK, Yang SW, Park MH, Lee HK, Park KS (2007) Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 50:2276–2279PubMedCrossRef
19.
go back to reference Joung KH, Kim HJ, Ku BJ (2011) Type B insulin resistance syndrome with diabetic ketoacidosis. Acta Diabetol PMID: 21387198. (Epub ahead of print) Joung KH, Kim HJ, Ku BJ (2011) Type B insulin resistance syndrome with diabetic ketoacidosis. Acta Diabetol PMID: 21387198. (Epub ahead of print)
20.
go back to reference Picarelli A, Di Tola M, Sabbatella L, Mercuri V, Pietrobono D, Bassotti G, D’Amico T, Donato G, Picarelli G, Marino M, Borghini R, Centanni M, Gargiulo P (2011) Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol PMID:21691748. (Epub ahead of print) Picarelli A, Di Tola M, Sabbatella L, Mercuri V, Pietrobono D, Bassotti G, D’Amico T, Donato G, Picarelli G, Marino M, Borghini R, Centanni M, Gargiulo P (2011) Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol PMID:21691748. (Epub ahead of print)
21.
go back to reference Shimada A, Morimoto J, Kodama K, Oikawa Y, Irie J, Nakagawa Y, Narumi S, Saruta T (2002) T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes. Diabetes Care 25:635–636PubMedCrossRef Shimada A, Morimoto J, Kodama K, Oikawa Y, Irie J, Nakagawa Y, Narumi S, Saruta T (2002) T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes. Diabetes Care 25:635–636PubMedCrossRef
22.
go back to reference Nakagawa Y, Shimada A, Oikawa Y, Irie J, Shigihara T, Tsumura K, Narumi S, Saruta T (2003) Two cases of “fulminant” type 1 diabetes suggesting involvement of autoimmunity. Ann N Y Acad Sci 1005:359–361PubMedCrossRef Nakagawa Y, Shimada A, Oikawa Y, Irie J, Shigihara T, Tsumura K, Narumi S, Saruta T (2003) Two cases of “fulminant” type 1 diabetes suggesting involvement of autoimmunity. Ann N Y Acad Sci 1005:359–361PubMedCrossRef
23.
go back to reference Ekholm E, Gottsater A, Dahlin LB, Sundkvist G (2011) No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol PMID: 21416148. (Epub ahead of print) Ekholm E, Gottsater A, Dahlin LB, Sundkvist G (2011) No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol PMID: 21416148. (Epub ahead of print)
24.
go back to reference Imagawa A, Hanafusa T (2006) Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 3:169–177PubMedCrossRef Imagawa A, Hanafusa T (2006) Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 3:169–177PubMedCrossRef
25.
go back to reference Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, Kobayashi T (2009) Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 58:732–737PubMedCrossRef Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, Kobayashi T (2009) Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 58:732–737PubMedCrossRef
26.
go back to reference Shibasaki S, Imagawa A, Tauriainen S, Iino M, Oikarinen M, Abiru H, Tamaki K, Seino H, Nishi K, Takase I, Okada Y, Uno S, Murase-Mishiba Y, Terasaki J, Makino H, Shimomura I, Hyoty H, Hanafusa T (2010) Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J 57:211–219PubMedCrossRef Shibasaki S, Imagawa A, Tauriainen S, Iino M, Oikarinen M, Abiru H, Tamaki K, Seino H, Nishi K, Takase I, Okada Y, Uno S, Murase-Mishiba Y, Terasaki J, Makino H, Shimomura I, Hyoty H, Hanafusa T (2010) Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J 57:211–219PubMedCrossRef
27.
go back to reference Ferraccioli G, Gremese E, De Santis M (2008) B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. Acta Diabetol 45:195–196PubMedCrossRef Ferraccioli G, Gremese E, De Santis M (2008) B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. Acta Diabetol 45:195–196PubMedCrossRef
Metadata
Title
Fulminant type 1 diabetes: a collaborative clinical cases investigation in China
Authors
Shuoming Luo
Zhenyi Zhang
Xia Li
Lin Yang
Jian Lin
Xiang Yan
Zhen Wang
Chao Zheng
Gan Huang
Zhiguang Zhou
Publication date
01-02-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0362-1

Other articles of this Issue 1/2013

Acta Diabetologica 1/2013 Go to the issue